Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole‐slide histopathology
The Journal of Pathology: Clinical Research · 2026
DOI: 10.1002/2056-4538.70082 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, 2026. Verfasst von Anne Petzold und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Fri…. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms, Cutaneous Squamous Cell Carcinoma, Deep Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Distinguishing infiltrative basal cell carcinoma (BCC) from poorly differentiated cutaneous squamous cell carcinoma (cSCC) remains a significant histopathological challenge. Automated deep learning approaches hold promise for improving diagnostic reliability, yet robust external validation is essential. In this study, we developed a weakly supervised deep learning model to classify these diagnostically challenging subtypes and evaluated its generalizability across internal and external cohorts, as well as in comparison to a dermatopathology foundation model (HistoGPT). The model employed a multiple‐instance learning framework (CLAM) using the histopathology‐specific transformer Phikon for feature extraction from whole‐slide images. Slide‐level ground‐truth diagnoses from the collected images ( n = 335, University Hospital Erlangen) were derived from routine clinical practice and re‐evaluated by two board‐certified dermatopathologists. Performance was assessed on an internal test set of 84 whole‐slide images (27 cSCC and 57 BCC) and two external datasets: Queensland cohort ( n = 10, curated in‐distribution cases) and the COBRA cohort ( n = 200, broad, partly out‐of‐distribution cases). Model discrimination was quantified using ROC curves, while accuracy, sensitivity, and specificity were reported alongside 95% Wilson confidence intervals (CIs). On the internal test set, the model achieved perfect classification [area under the receiver operating characteristic (AUC) = 1.0; 100% accuracy, sensitivity, and specificity]. Similarly, strong performance was observed in the Queensland cohort (AUC = 1.0), although limited by sample size. In the more heterogeneous COBRA cohort, discrimination remained high (AUC = 0.923, 95% CI 0.885–0.961), requiring threshold adjustment to correct for marked calibration shift (balanced accuracy 86.5% at Youden's J ). Attention heatmaps highlighted histologically meaningful regions. In zero‐shot evaluation on the internal test set, HistoGPT achieved an overall accuracy of 77%, with high class‐wise sensitivity for BCC (98%, 95% CI 91–100) but markedly reduced sensitivity for cSCC (33%, 95% CI 19–52). Fine‐tuning a task‐specific classifier on the HistoGPT backbone substantially improved performance, achieving near‐perfect discrimination and 98% balanced accuracy. These findings demonstrate that weakly supervised deep learning enables highly accurate classification of diagnostically challenging BCC and cutaneous squamous cell carcinoma subtypes. However, reliable deployment across institutions necessitates careful calibration and domain adaptation, and even powerful foundation models such as HistoGPT benefit from targeted fine‐tuning to ensure robust performance in dermatopathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, German…
- Laboratory for Dermatopathology, Oral Pathology and Molecular Pathology, Dermpath München, Munich, Germany.
- Institute of AI for Health, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
- Department of Mathematics, Technical University of Munich, Munich, Germany.
- Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
- Helmholtz AI, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
ORCID-Profile: Elias At Koch, Carola Berking, Markus V Heppt
Zitieren
APA
Petzold, A., Wessely, A., Schliep, S., Jiang, H., Tran, M., Koch, E. A., Peng, T., Starz, H., Berking, C., Marr, C., & Heppt, M. V. (2026). Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole‐slide histopathology. The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.70082
Vancouver
Petzold A, Wessely A, Schliep S, Jiang H, Tran M, Koch EA, et al. Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole‐slide histopathology. The Journal of Pathology: Clinical Research. 2026. doi:10.1002/2056-4538.70082
BibTeX
@article{Petzold2026,
author = {Petzold, Anne and Wessely, Anja and Schliep, Stefan and Jiang, Hong and Tran, Manuel and Koch, Elias At and Peng, Tingying and Starz, Hans and Berking, Carola and Marr, Carsten and Heppt, Markus V},
title = {Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole‐slide histopathology},
journal = {The Journal of Pathology: Clinical Research},
year = {2026},
doi = {10.1002/2056-4538.70082}
}
EUVIMED